Detalhe da pesquisa
1.
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence.
Cell
; 179(1): 236-250.e18, 2019 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495571
2.
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.
Immunity
; 42(2): 344-355, 2015 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25680274
3.
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy.
Cancer Immunol Immunother
; 70(6): 1541-1555, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33201337
4.
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy.
Cancer Immunol Immunother
; 61(10): 1833-47, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22441657
5.
Novel anti-melanoma immunotherapies: disarming tumor escape mechanisms.
Clin Dev Immunol
; 2012: 818214, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22778766
6.
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.
Science
; 371(6529): 602-609, 2021 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33303685
7.
Systemic dysregulation of CEACAM1 in melanoma patients.
Cancer Immunol Immunother
; 59(2): 215-30, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19633846
8.
Immune co-culture cell microarray - a feasible tool for high-throughput functional investigation of lymphocyte-cancer interactions.
Oncoimmunology
; 9(1): 1741267, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32373399
9.
Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells.
Neoplasia
; 20(4): 401-409, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29558679
10.
ADAR1-mediated regulation of melanoma invasion.
Nat Commun
; 9(1): 2154, 2018 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29855470
11.
SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.
Oncotarget
; 7(21): 30166-77, 2016 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26885752
12.
CEACAM1-Mediated Inhibition of Virus Production.
Cell Rep
; 15(11): 2331-9, 2016 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27264178
13.
A longitudinal study of CEACAM1 expression in melanoma disease progression.
Oncol Rep
; 33(3): 1314-8, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25573088
14.
CEACAM1 promotes melanoma cell growth through Sox-2.
Neoplasia
; 16(5): 451-60, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24931667
15.
Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studies.
PLoS One
; 8(3): e57922, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23483943
16.
Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma.
PLoS One
; 8(2): e57160, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23451174
17.
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.
J Clin Invest
; 123(6): 2703-18, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23728176
18.
Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions.
Mol Cancer Ther
; 11(6): 1300-10, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22466331
19.
Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
Invest Ophthalmol Vis Sci
; 52(13): 9368-72, 2011 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22039239
20.
Regulation of cancer aggressive features in melanoma cells by microRNAs.
PLoS One
; 6(4): e18936, 2011 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21541354